Our strength is in our breadth
ANTG produce exclusive high-quality cannabinoid based medicinal treatments that can meet individual patient needs.
Our team has witnessed first-hand the power of medicinal cannabis in relieving chronic and debilitating disease symptoms in areas where traditional treatments lack efficacy and or have significant side effects.
Our focus is on putting the needs of patients first – and we believe, as an independent company, that we are uniquely positioned to achieve more. That’s why we are committed to investing in research and development, both in-house as well as partnering with key universities to undertake cannabis research and support clinical trial programs.
Led by a board of skilled commercial leaders, our team also includes experienced horticulturists, scientific researchers and medical advisors.
TIKUN helps patients who seek improved health outcomes with leading medical cannabis treatments.
Australia has some of the world's most innovative health initiatives. It also has some of the best growing climates on the globe.
TIKUN combines these great advantages, developed with decades of research in medical cannabis, to deliver a new era to modern medicine.
A doctor led group of companies that is patient focused to provide high quality service and cannabis products.
iX Syrinx is an expanding global company that is dedicated to improving health outcomes for its clients with its range of pharmaceutical and nutraceutical products.
Its scientists combine formulation know-how and oral, topical or sublingual delivery technologies to create unique and innovative solutions for pharmaceutical use and consumer health.
It uses its deep wealth of experience in pharmaceutical delivery using WaferiX to support our customers in developing medicines and nutraceuticals that are absorbed faster, have improved bioavailability, and have a faster onset of action.
Scitek is a provider of high end equipment to the scientific community.
As a company, it strives to go above and beyond the supply of products alone.
It aims towards setting a benchmark in offering a complete service from day one.
With engineers with over 30 years of experience in their field and trained by its overseas suppliers, Scitek is capable of solving any issue or inquiry to ensure class-leading competence in the products and technologies it represents.
Cymra Life Sciences is an Australian owned licenced cultivator and manufacturer of medical cannabis. Its focus is to cultivate full spectrum medicines to enhance the lives of people living in chronic and neuropathic pain.
Cymra is the only cannabis company in Australia, and one of a few worldwide, focusing on the genetic development and supply to cannabis cultivators.
Cymra is harnessing plant genetics to create novel pain medicines from unique cultivars. It is researching all compounds of the plant and testing in formulations to understand how they may work in synergy to improve inflammation and pain.
United in Compassion is Australia’s Peak Medicinal Cannabis advocacy body which helped bring about the 2016 legislative changes that made lawful cultivation of the plant for medical and research purposes possible.
Founded in 2014 by Lucy Haslam and her late son Dan, UIC’s main functions since then have been to promote education and knowledge around clinical uses of cannabis as well campaigning for improved patient access to what, for many, can be a life-saving medicine. This is in light of the fact that the 2016 Amendments to the Narcotic Drugs Act have failed and are failing to deliver on the promise to deliver affordable cannabis products for sick Australians who need them.
UIC's philosophy is the dignified alleviation of suffering with compassion and empathy according to ‘Dan’s Test.’
Its primary mission is advocating for patient access to Full Spectrum herbal Medicinal Cannabis extracts and dried herb cannabis in a manner which is safe, effective, affordable, equitable and favourable to patients.
Dan’s test sets expectations of high quality products that are legally and easily accessible with no patient left behind.
Such products should be:
Dan Haslam was instrumental in bringing the issue of the therapeutic use of herbal Medicinal Cannabis to the forefront and into the national Australian consciousness. He benefited dramatically from his use of local Australian grown herbal medicinal varieties of cannabis during his battle with cancer.
Though he passed away on the 24th of February 2015, his legacy lives on.
‘Every step we take on Medical Cannabis, will be built on the footsteps Dan Haslam left behind.’
Mike Baird – Premier of New South Wales
The Country Women’s Association of Australia (CWAA) was formed in 1945 to provide a single voice to the Federal Government on behalf of the individual State and Territory Associations. The first of these was NSW, which formed in 1922. Other mainland states had formed by 1928 and Tasmania by 1936.
All Country Women’s Associations are non-sectarian, non-party-political and not-for-profit.
The National body is a Company Limited by Guarantee and interacts with the States and Territory under a Federated Model. It is the largest Women's NGO in Australia with over 17,000 members.
Its Objective is to advance the rights and equity of women, families and communities in Australia through advocacy and empowerment, especially for those living in regional, rural and remote Australia.
CWA is affiliated with the Associated Country Women of the World (ACWW) which represents over 9 million rural women in 75 countries worldwide and works to, among other things, raise the standard of living, provide practical support for women and girls and eliminate gender discrimination.
Its membership is diverse and includes women from all age groups; from urban and rural areas; from indigenous and CALD communities; working and retired.
Cannim is built on three core principles, safety, science and scale.
Cannim believes these are necessary to be successful in the medicinal cannabis arena. The cannabis industry is plighted with product inconsistency and unfounded claims. Through keeping these values at the foundation of everything it does, Cannim is able to ensure quality cannabis and consistency of supply for healthier outcomes.
Based on its core principles, Cannim has put itself in the forefront of Cannabinoid research, utilising state of the art operating procedures to ensure safe, effective and consistent products.
The large investments in farms located in Jamaica and Australia enables production at a significant scale.
A leading Australian Medicinal Cannabis producer fully licensed to supply affordable high-quality medicinal cannabis to the Australian and export markets. Murray Meds medicinal cannabis is grown organically on the banks of Australia’s largest river – the mighty Murray. The secure location provides abundant access to natural resources which reduces the need for chemicals and power and helps to keep a low carbon footprint. Murray Meds cannabis cultivation practices strive for a dynamic, holistic and sustainable approach, focussing on regenerative agriculture and organic farming practices.
The founder of United in Compassion, the leading NGO for medicinal cannabis, Lucy Haslam is also a founding member, Board Director and Chair of AMCA.
Passionate about access and affordability for patients, Lucy registered UIC (https://unitedincompassion.com.au/), as a member organisation of AMCA as soon as it was formed, and will work through both associations to advocate for, and further the interests of, patients in need.
Lucy continues to campaign tirelessly and, as well as organising the 2021 UIC Symposium being held from August 13-15 2021 at the Sunshine Coast, she has also been instrumental in driving the development of the online Australian Medicinal Cannabis Course For Health Professionals which has just launched (https://medicalcannabiscourse.com.au)
We are currently welcoming other organisations to become members to help us to shape the future of our industry for the benefit of the sector and the patients and carers that it serves.
Jodie was the first person to sign up for individual membership on the day that AMCA launched - 15th July 2020
Jodie is, in her own words, a "huge advocate for medicinal cannabis". As well as being a member of United in Compassion, Jodie is Federal Education Officer of the Australian Nursing and Midwifery Federation and has been charged with developing a conference (post-Covid 19) for nurses and midwives about Medicinal Cannabis. She has also written an education piece for nurses and midwives which is available on the online education portal (http://anmf.org.au/education).
Pleased to welcome you as a member, Jodie.
As well as Jodie, since we launched last Wednesday, we have welcomed other individual nurses, doctors and researchers signing up to also become members of AMCA.
We look forward to welcoming many more individuals to join AMCA and its member organisations to make this unique treatment more accessible and affordable. for patients.